BICLUSTER_ID : UPREG-38
PATHOGENS /3/ : escherichia coli,yersinia enterocolitica,helicobacter pylori
TARGETS /18/ : ALDH1A2, CD44, CCL2, SERPINB2, VCAM1, AMPD3, GCH1, CCL5, PIM1, BRAF, NFKB1, JAK2, IL6, F3, PTGS2, IL1R1, PLAUR, TNF
Gene SetLeading Edge Genes
NETPATH IL 4 PATHWAY UPNFKB1, ALDH1A2, REL, ETV3, IBRDC3, CCL2, VCAM1, IL6, EXT1, F3, RIPK2, SLC11A2, UPP1, PTX3
NETPATH IL 1 PATHWAY UPNFKB1, LIF, CXCL1, PLK2, CCL2, HBEGF, CCL7, IL6, PTGS2, AMPD3, CXCL2, PTX3
NETPATH IL 2 PATHWAY UPNFKB1, KLF6, LIF, GADD45G, ETS2, PTP4A1, PMAIP1, IL6, PIM1, IRF1, UPP1, IL1R1, BHLHB2, PLAUR, CFLAR
NCI IL23PATHWAYNFKB1, IL6, CXCL1, JAK2, IL23A, CCL2
NETPATH KIT RECEPTOR PATHWAY UPIL6, JUNB, CCL5, CCL2, PIM1, IER3
NETPATH IL 7 PATHWAY UPCXCL1, CCL5, CD44, CXCL2, BRAF
GERY CEBP TARGETSGADD45B, CXCL1, JUNB, GADD45G, ATF3, GCH1, PIM1, DUSP1, PLAUR
NETPATH IL 4 PATHWAY DOWNIL6, GEM, GADD45B, PTGS2, CCL2, CXCL2, IRF1
NETPATH IL 5 PATHWAY UPPLSCR1, REL, CCL2, CD44, PIM1, UPP1, CASP4
NETPATH EGFR1 PATHWAY UPDDX21, LIF, CDKN1A, PLK2, SERPINB2, AREG, TNFAIP3, PTGS2, PLAUR, DUSP1
NETPATH TNF ALPHA PATHWAY DOWNKLF6, REL, CXCL1, JUNB, PLK2, MAFF, IL6, GEM, PTGS2, TNFAIP3, IRF1, CXCL2, BHLHB2
NETPATH IL 6 PATHWAY UPGADD45B, CXCL1, JUNB, CD44, MAFF, PIM1, IRF1, BHLHB2
NCI NFKAPPABCANONICALPATHWAYNFKB1, TNFAIP3, RIPK2, TNF
NETPATH IL 9 PATHWAY UPCCL7, CCL2, JUNB
NETPATH IL 1 PATHWAYIL1R1
NCI IL1PATHWAYIL1R1
NCI VWF INTERACTION WITH COLLAGEN
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
BIOCARTA STEM PATHWAY
BIOCARTA NFKB PATHWAY
MAHAJAN RESPONSE TO IL1A UP
WEINMANN ADAPTATION TO HYPOXIA DN
VANHARANTA UTERINE FIBROID DN
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
CHEN LVAD SUPPORT OF FAILING HEART UP
REACTOME PEPTIDE LIGAND BINDING RECEPTORS
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
RASHI RESPONSE TO IONIZING RADIATION 2
LINDSTEDT DENDRITIC CELL MATURATION A
RADAEVA RESPONSE TO IFNA1 UP
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
ODONNELL TFRC TARGETS UP
ELVIDGE HYPOXIA UP
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
CORUM IKBBETA-RELA-CREL COMPLEX
AMIT EGF RESPONSE 40 HELA
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
ROETH TERT TARGETS UP
BIOCARTA LAIR PATHWAY
NUYTTEN NIPP1 TARGETS UP
HINATA NFKB TARGETS KERATINOCYTE UP
DORN ADENOVIRUS INFECTION 48HR DN
MARKEY RB1 ACUTE LOF UP
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
MURATA VIRULENCE OF H PILORI
XU HGF TARGETS INDUCED BY AKT1 48HR UP
OSADA ASCL1 TARGETS DN
AMIT SERUM RESPONSE 60 MCF10A
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS MAGENTA UP
HAN SATB1 TARGETS DN
SABATES COLORECTAL ADENOMA UP
DIRMEIER LMP1 RESPONSE EARLY
KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION
SEMENZA HIF1 TARGETS
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
NCI NFAT TFPATHWAY
ZHOU INFLAMMATORY RESPONSE LIVE UP
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
ONDER CDH1 TARGETS 3 DN
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLUE UP
DEBOSSCHER NFKB TARGETS REPRESSED BY GLUCOCORTICOIDS
AMIT EGF RESPONSE 120 HELA
BIOCARTA RANKL PATHWAY
HELLEBREKERS SILENCED DURING TUMOR ANGIOGENESIS
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
NCI CHEMOKINE RECEPTORS BIND CHEMOKINES
VART KSHV INFECTION ANGIOGENIC MARKERS DN
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
DAZARD RESPONSE TO UV NHEK UP
MCLACHLAN DENTAL CARIES UP
WINTER HYPOXIA METAGENE
GAJATE RESPONSE TO TRABECTEDIN UP
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX CHUK KPNA3 NFKB2 NFKBIB REL IKBKG NFKB1 NFKBIE RELB NFKBIA RELA TNIP2
PODAR RESPONSE TO ADAPHOSTIN UP
SHAFFER IRF4 TARGETS IN PLASMA CELL VS MATURE B LYMPHOCYTE
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
FOSTER INFLAMMATORY RESPONSE LPS DN
TAVOR CEBPA TARGETS UP
RAY ALZHEIMERS DISEASE
GAURNIER PSMD4 TARGETS
HELLER SILENCED BY METHYLATION UP
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
MARKEY RB1 CHRONIC LOF DN
NCI AMB2 NEUTROPHILS PATHWAY
SMID BREAST CANCER LUMINAL B DN
ZHOU INFLAMMATORY RESPONSE LPS UP
GESERICK TERT TARGETS DN
WONG ENDMETRIUM CANCER UP
AMIT SERUM RESPONSE 120 MCF10A
BROWNE HCMV INFECTION 2HR UP
DORN ADENOVIRUS INFECTION 24HR DN
SESTO RESPONSE TO UV C3
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
GEISS RESPONSE TO DSRNA UP
NCI P53DOWNSTREAMPATHWAY
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX RPL6 RPL30 RPS13 CHUK DDX3X NFKB2 NFKBIB REL IKBKG NFKB1 MAP3K8 RELB GLG1 NFKBIA RELA TNIP2 GTF2I
CORUM IKBEPSILON-RELA-CREL COMPLEX
NCI IL12 2PATHWAY
ZHOU INFLAMMATORY RESPONSE FIMA UP
CHASSOT SKIN WOUND
TIAN TNF SIGNALING VIA NFKB
ZHU CMV ALL UP
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
OKUMURA INFLAMMATORY RESPONSE LPS
GENTILE UV LOW DOSE UP
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE
SMID BREAST CANCER RELAPSE IN PLEURA DN
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN
AMIT EGF RESPONSE 60 MCF10A
HINATA NFKB TARGETS FIBROBLAST UP
NOJIMA SFRP2 TARGETS UP
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
CHEN HOXA5 TARGETS 6HR UP
MISSIAGLIA REGULATED BY METHYLATION UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
NCI ATF2 PATHWAY
MOHANKUMAR TLX1 TARGETS DN
RODRIGUES THYROID CARCINOMA DN
DORN ADENOVIRUS INFECTION 32HR DN
AUJLA IL22 AND IL17A SIGNALING
CROONQUIST STROMAL STIMULATION UP
SA MMP CYTOKINE CONNECTION
HALMOS CEBPA TARGETS UP
WALLACE PROSTATE CANCER RACE UP
SIMBULAN UV RESPONSE NORMAL UP
HORIUCHI WTAP TARGETS UP
DACOSTA ERCC3 ALLELE XPCS VS TTD UP
ONDER CDH1 SIGNALING VIA CTNNB1
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
DORN ADENOVIRUS INFECTION 12HR UP
MAHADEVAN RESPONSE TO MP470 DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
HARRIS HYPOXIA
DER IFN BETA RESPONSE UP
SCHAVOLT TARGETS OF TP53 AND TP63
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
DIRMEIER LMP1 RESPONSE LATE UP
AMIT EGF RESPONSE 20 HELA
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D DN
MUELLER METHYLATED IN GLIOBLASTOMA
KAN RESPONSE TO ARSENIC TRIOXIDE
BASSO CD40 SIGNALING UP
NAGASHIMA NRG1 SIGNALING UP
MARZEC IL2 SIGNALING UP
SOUCEK MYC TARGETS
BIOCARTA PPARA PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
ZERBINI RESPONSE TO SULINDAC UP
BILBAN B CLL LPL DN
CROMER TUMORIGENESIS UP
GENTILE UV LOW DOSE DN
MAHADEVAN RESPONSE TO MP470 UP
FERRARI RESPONSE TO FENRETINIDE UP
KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY
SHAFFER IRF4 MULTIPLE MYELOMA PROGRAM
BILD HRAS ONCOGENIC SIGNATURE
AMUNDSON GAMMA RADIATION RESISTANCE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
NETPATH IL 3 PATHWAY UP
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
KEGG LEISHMANIA INFECTION
LEE LIVER CANCER ACOX1 UP
WU HBX TARGETS 1 UP
AMIT EGF RESPONSE 60 HELA
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
BERENJENO TRANSFORMED BY RHOA FOREVER DN
CHEN HOXA5 TARGETS 9HR UP
DAZARD UV RESPONSE CLUSTER G2
MCLACHLAN DENTAL CARIES DN
AMIT SERUM RESPONSE 40 MCF10A
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
BROWNE HCMV INFECTION 4HR UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
WONG ENDOMETRIAL CANCER LATE
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
ZHU CMV 8 HR UP
BIERIE INFLAMMATORY RESPONSE TGFB1
ENGELMANN CANCER PROGENITORS UP
BIOCARTA INFLAM PATHWAY
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP
SANA TNF SIGNALING UP
DACOSTA ERCC3 ALLELE XPCS VS TTD DN
SENESE HDAC1 AND HDAC2 TARGETS UP
FOSTER INFLAMMATORY RESPONSE LPS UP
RICKMAN HEAD AND NECK CANCER C
WANG METHYLATED IN BREAST CANCER
XU HGF TARGETS INDUCED BY AKT1 6HR
EBAUER TARGETS OF PAX3 FOXO1 FUSION UP
ONDER CDH1 TARGETS 2 DN
SENESE HDAC1 TARGETS UP
LIU TARGETS OF VMYB VS CMYB DN
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
KIM WT1 TARGETS UP
SENESE HDAC3 TARGETS UP
KEGG CHEMOKINE SIGNALING PATHWAY
ONDER CDH1 TARGETS 1 DN
KEGG CYTOSOLIC DNA SENSING PATHWAY
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
KOBAYASHI EGFR SIGNALING 6HR DN
BIOCARTA GRANULOCYTES PATHWAY
DORSAM HOXA9 TARGETS DN
HESS TARGETS OF HOXA9 AND MEIS1 DN
DASU IL6 SIGNALING UP
ELVIDGE HYPOXIA BY DMOG UP
AMIT EGF RESPONSE 120 MCF10A
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
ZUCCHI METASTASIS DN
BRUECKNER TARGETS OF MIRLET7A3 UP
RUTELLA RESPONSE TO HGF UP
PRAMOONJAGO SOX4 TARGETS UP
WATTEL AUTONOMOUS THYROID ADENOMA DN
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
yersinia enterocolitica wap bl6yersinia enterocolitica p60 bl6helicobacter pylori kx2 mgepescherichia coliGeneSet Name
0.00016 0.00010 0.00426 0.00129NETPATH_IL_4_PATHWAY_UP
0.00024 0.00000 0.00000 0.00000NETPATH_IL_1_PATHWAY_UP
0.01769 0.00994 0.04909 0.00000NETPATH_IL_2_PATHWAY_UP
0.00000 0.00000 0.01454 0.00000NCI_IL23PATHWAY
0.00062 0.00015 0.00355 0.00023NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00623 0.00709 0.00019 0.00000NETPATH_IL_7_PATHWAY_UP
0.00277 0.00040 0.00038 0.01389GERY_CEBP_TARGETS
0.00145 0.00146 0.00009 0.00000NETPATH_IL_4_PATHWAY_DOWN
0.02712 0.00711 0.00002 0.00001NETPATH_IL_5_PATHWAY_UP
0.04029 0.00038 0.07001 0.00008NETPATH_EGFR1_PATHWAY_UP
0.00024 0.00010 0.00340 0.00002NETPATH_TNF_ALPHA_PATHWAY_DOWN
0.00000 0.00000 0.01969 0.00000NETPATH_IL_6_PATHWAY_UP
0.11497 0.04764 0.01694 0.00009NCI_NFKAPPABCANONICALPATHWAY
0.00016 0.00016 0.00202 0.00028NETPATH_IL_9_PATHWAY_UP
0.04934 0.02533 0.00458 0.00003NETPATH_IL_1_PATHWAY
0.05191 0.04794 0.02503 0.00686NCI_IL1PATHWAY
0.15144 0.16999 0.19572 0.10123NCI_VWF_INTERACTION_WITH_COLLAGEN
0.00000 0.00021 0.00541 0.00000GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00467 0.03650 0.00925 0.00008BIOCARTA_STEM_PATHWAY
0.11451 0.05121 0.00304 0.00000BIOCARTA_NFKB_PATHWAY
0.00113 0.00010 0.00001 0.00000MAHAJAN_RESPONSE_TO_IL1A_UP
0.00024 0.00006 0.02716 0.00000WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.01495 0.03690 0.00272 0.00612VANHARANTA_UTERINE_FIBROID_DN
0.00000 0.00011 0.07361 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.02279 0.00019 0.00040 0.00159CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.00006 0.00054 0.06781 0.00015REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.04571 0.04591 0.00000 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00017 0.00114 0.00292 0.00000BIOCARTA_IL1R_PATHWAY
0.00427 0.00297 0.00000 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00011 0.00029 0.00000 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.00075 0.00709 0.10408 0.00000RADAEVA_RESPONSE_TO_IFNA1_UP
0.03142 0.00543 0.02379 0.00127LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.15209 0.04740 0.06928 0.14941ODONNELL_TFRC_TARGETS_UP
0.00923 0.00031 0.00095 0.01124ELVIDGE_HYPOXIA_UP
0.05090 0.00563 0.01339 0.00026IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.07007 0.07364 0.12920 0.10934CORUM_IKBBETA-RELA-CREL_COMPLEX
0.01474 0.00021 0.00053 0.00000AMIT_EGF_RESPONSE_40_HELA
0.00024 0.00184 0.00010 0.00000THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.01109 0.00708 0.09686 0.00220TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.05386 0.09575 0.08283 0.00141ROETH_TERT_TARGETS_UP
0.00578 0.00330 0.00141 0.05748BIOCARTA_LAIR_PATHWAY
0.13690 0.14988 0.14612 0.00110NUYTTEN_NIPP1_TARGETS_UP
0.00000 0.00000 0.00000 0.00000HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.19614 0.00341 0.00009 0.00089DORN_ADENOVIRUS_INFECTION_48HR_DN
0.00200 0.01647 0.09595 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.00045 0.00058 0.00019 0.00000KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.05736 0.05814 0.10066 0.00130MURATA_VIRULENCE_OF_H_PILORI
0.03329 0.01826 0.19637 0.00136XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.08327 0.08169 0.14030 0.00002OSADA_ASCL1_TARGETS_DN
0.00000 0.00000 0.00000 0.00109AMIT_SERUM_RESPONSE_60_MCF10A
0.00615 0.00356 0.02487 0.00000NUYTTEN_EZH2_TARGETS_UP
0.00646 0.00201 0.00000 0.00000DUTTA_APOPTOSIS_VIA_NFKB
0.19398 0.10560 0.04284 0.02827GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.06100 0.05253 0.02340 0.01800HAN_SATB1_TARGETS_DN
0.03793 0.00162 0.05261 0.00112SABATES_COLORECTAL_ADENOMA_UP
0.00000 0.00018 0.00124 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.10664 0.13918 0.13453 0.00010KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.01510 0.00609 0.00002 0.14703SEMENZA_HIF1_TARGETS
0.00002 0.00012 0.00000 0.00000REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.06500 0.15482 0.09081 0.00004NCI_NFAT_TFPATHWAY
0.00000 0.00000 0.00000 0.00000ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.19163 0.06839 0.13593 0.01985RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.00150 0.00026 0.00020 0.00000ONDER_CDH1_TARGETS_3_DN
0.00200 0.00032 0.00044 0.00155GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.19623 0.17962 0.12727 0.02153DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.00077 0.00029 0.00007 0.00046AMIT_EGF_RESPONSE_120_HELA
0.05455 0.07528 0.04291 0.05932BIOCARTA_RANKL_PATHWAY
0.07010 0.02280 0.11815 0.00004HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.03866 0.02528 0.00467 0.04537NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.04689 0.01398 0.17390 0.04474NCI_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.08508 0.02317 0.05576 0.08667VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
0.09112 0.07195 0.17266 0.00949FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
0.10871 0.10917 0.00622 0.00438NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.08717 0.01128 0.01957 0.00002DAZARD_RESPONSE_TO_UV_NHEK_UP
0.00049 0.00050 0.00006 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.06926 0.01519 0.00315 0.02164WINTER_HYPOXIA_METAGENE
0.09603 0.02695 0.10731 0.00098GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.09646 0.07034 0.00012 0.00012CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_CHUK_KPNA3_NFKB2_NFKBIB_REL_IKBKG__NFKB1_NFKBIE_RELB__NFKBIA_RELA_TNIP2
0.00017 0.00000 0.00000 0.01026PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.00519 0.00305 0.07351 0.05575SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.00409 0.00056 0.00092 0.10160GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.00000 0.00000 0.00146 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.15470 0.06979 0.04908 0.00020TAVOR_CEBPA_TARGETS_UP
0.06510 0.03429 0.02855 0.01926RAY_ALZHEIMERS_DISEASE
0.00000 0.00000 0.00000 0.00000GAURNIER_PSMD4_TARGETS
0.00210 0.00251 0.08092 0.00002HELLER_SILENCED_BY_METHYLATION_UP
0.04808 0.00980 0.15948 0.00071SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.00491 0.00471 0.05877 0.09710MARKEY_RB1_CHRONIC_LOF_DN
0.03531 0.17478 0.08235 0.00044NCI_AMB2_NEUTROPHILS_PATHWAY
0.00087 0.00018 0.18998 0.00006SMID_BREAST_CANCER_LUMINAL_B_DN
0.00000 0.00000 0.00059 0.00000ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.00141 0.00000 0.00002 0.00083GESERICK_TERT_TARGETS_DN
0.02941 0.05178 0.07293 0.12623WONG_ENDMETRIUM_CANCER_UP
0.00013 0.00007 0.00109 0.00011AMIT_SERUM_RESPONSE_120_MCF10A
0.06014 0.00222 0.00890 0.00014BROWNE_HCMV_INFECTION_2HR_UP
0.09507 0.00061 0.00000 0.00667DORN_ADENOVIRUS_INFECTION_24HR_DN
0.00757 0.00078 0.00018 0.00001SESTO_RESPONSE_TO_UV_C3
0.00001 0.00000 0.00145 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.01123 0.04624 0.00158 0.00002BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.00179 0.00109 0.00000 0.00000GEISS_RESPONSE_TO_DSRNA_UP
0.08860 0.11365 0.11095 0.00831NCI_P53DOWNSTREAMPATHWAY
0.05337 0.09809 0.03289 0.00003CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_RPL6_RPL30_RPS13_CHUK_DDX3X_NFKB2_NFKBIB_REL_IKBKG_NFKB1_MAP3K8_RELB_GLG1_NFKBIA_RELA_TNIP2__GTF2I
0.15414 0.16341 0.06982 0.08427CORUM_IKBEPSILON-RELA-CREL_COMPLEX
0.00709 0.00272 0.10946 0.00000NCI_IL12_2PATHWAY
0.00018 0.00000 0.00011 0.00000ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.13170 0.07095 0.00239 0.17603CHASSOT_SKIN_WOUND
0.00000 0.00016 0.00000 0.00000TIAN_TNF_SIGNALING_VIA_NFKB
0.02045 0.03630 0.01057 0.00000ZHU_CMV_ALL_UP
0.00027 0.01680 0.01658 0.00000KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.09623 0.00621 0.14096 0.00002OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.05500 0.00394 0.13892 0.11450GENTILE_UV_LOW_DOSE_UP
0.00139 0.00058 0.10358 0.00010LEE_LIVER_CANCER_HEPATOBLAST
0.00000 0.00000 0.00000 0.00003NAGASHIMA_EGF_SIGNALING_UP
0.17951 0.08889 0.19227 0.02074REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE
0.02580 0.01466 0.07335 0.09662SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN
0.00032 0.00005 0.15311 0.00492CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.00000 0.00000 0.00000 0.00000AMIT_EGF_RESPONSE_60_MCF10A
0.03435 0.00034 0.00009 0.00000HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00172 0.00037 0.00000 0.00018NOJIMA_SFRP2_TARGETS_UP
0.10433 0.00176 0.05697 0.00000CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00000 0.00000 0.00022 0.00000KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.03187 0.01499 0.00788 0.13852CHEN_HOXA5_TARGETS_6HR_UP
0.00468 0.00038 0.00396 0.00000MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.05054 0.02220 0.06739 0.01400SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00000 0.00000 0.00000 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.19595 0.05363 0.00272 0.01874NCI_ATF2_PATHWAY
0.09623 0.05165 0.16855 0.05151MOHANKUMAR_TLX1_TARGETS_DN
0.01787 0.00115 0.00189 0.01801RODRIGUES_THYROID_CARCINOMA_DN
0.13670 0.00369 0.00009 0.00003DORN_ADENOVIRUS_INFECTION_32HR_DN
0.01525 0.00953 0.01624 0.00129AUJLA_IL22_AND_IL17A_SIGNALING
0.04761 0.00954 0.05041 0.00003CROONQUIST_STROMAL_STIMULATION_UP
0.00406 0.01474 0.11687 0.00133SA_MMP_CYTOKINE_CONNECTION
0.00185 0.00022 0.03870 0.00001HALMOS_CEBPA_TARGETS_UP
0.00001 0.00029 0.14952 0.00004WALLACE_PROSTATE_CANCER_RACE_UP
0.11226 0.13433 0.04290 0.01024SIMBULAN_UV_RESPONSE_NORMAL_UP
0.00735 0.01137 0.01380 0.00002HORIUCHI_WTAP_TARGETS_UP
0.09591 0.06442 0.19781 0.00108DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.05101 0.03049 0.00028 0.00015ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.01516 0.03385 0.01011 0.01179GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.00709 0.00175 0.00625 0.04767DORN_ADENOVIRUS_INFECTION_12HR_UP
0.00031 0.00072 0.00005 0.00317MAHADEVAN_RESPONSE_TO_MP470_DN
0.07134 0.00504 0.10649 0.00220CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.00250 0.00029 0.00009 0.00034HARRIS_HYPOXIA
0.04202 0.04762 0.12957 0.00000DER_IFN_BETA_RESPONSE_UP
0.17012 0.04121 0.11104 0.11465SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.05961 0.02538 0.00012 0.00002DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.15215 0.00164 0.04267 0.00000DIRMEIER_LMP1_RESPONSE_LATE_UP
0.16753 0.18824 0.00435 0.00089AMIT_EGF_RESPONSE_20_HELA
0.00195 0.00040 0.18617 0.10451TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.11405 0.08747 0.13657 0.19250MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.04922 0.00165 0.00248 0.02558KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.00000 0.00018 0.01278 0.00000BASSO_CD40_SIGNALING_UP
0.00002 0.00000 0.00000 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.00016 0.00021 0.01784 0.00002MARZEC_IL2_SIGNALING_UP
0.00000 0.00018 0.00002 0.00037SOUCEK_MYC_TARGETS
0.00493 0.02843 0.15599 0.17722BIOCARTA_PPARA_PATHWAY
0.00017 0.00000 0.01992 0.05842TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.13677 0.05840 0.00100 0.02814ZERBINI_RESPONSE_TO_SULINDAC_UP
0.02307 0.00270 0.12382 0.14289BILBAN_B_CLL_LPL_DN
0.03004 0.00030 0.10547 0.00002CROMER_TUMORIGENESIS_UP
0.06577 0.00320 0.15126 0.08643GENTILE_UV_LOW_DOSE_DN
0.00025 0.00018 0.00001 0.00000MAHADEVAN_RESPONSE_TO_MP470_UP
0.00508 0.01472 0.00002 0.00016FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.02548 0.06399 0.00254 0.00000KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.01088 0.00394 0.01650 0.00249SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.00208 0.00000 0.00132 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.03733 0.09360 0.05602 0.09083AMUNDSON_GAMMA_RADIATION_RESISTANCE
0.00000 0.00000 0.00002 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.05660 0.06189 0.00008 0.00003DAUER_STAT3_TARGETS_UP
0.00000 0.00000 0.13629 0.00000NETPATH_IL_3_PATHWAY_UP
0.00018 0.00000 0.01763 0.00000ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.00675 0.07814 0.01576 0.00028KEGG_LEISHMANIA_INFECTION
0.02761 0.02321 0.16748 0.13289LEE_LIVER_CANCER_ACOX1_UP
0.00703 0.00917 0.03293 0.00099WU_HBX_TARGETS_1_UP
0.02663 0.00019 0.00000 0.00523AMIT_EGF_RESPONSE_60_HELA
0.16114 0.08832 0.00073 0.08973ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.19546 0.00332 0.02345 0.00016BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.01506 0.00807 0.00000 0.00050CHEN_HOXA5_TARGETS_9HR_UP
0.11521 0.01250 0.00000 0.00004DAZARD_UV_RESPONSE_CLUSTER_G2
0.00078 0.00065 0.00040 0.00002MCLACHLAN_DENTAL_CARIES_DN
0.00000 0.00000 0.00219 0.00142AMIT_SERUM_RESPONSE_40_MCF10A
0.00000 0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00810 0.00398 0.00677 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00017 0.00019 0.04014 0.00000BROWNE_HCMV_INFECTION_4HR_UP
0.00369 0.00489 0.00000 0.08735CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.04702 0.04574 0.10814 0.06386WONG_ENDOMETRIAL_CANCER_LATE
0.00000 0.00000 0.00000 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00025 0.00061 0.11599 0.00000ZHU_CMV_8_HR_UP
0.07716 0.05248 0.00543 0.01522BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.10293 0.10778 0.05585 0.00403ENGELMANN_CANCER_PROGENITORS_UP
0.00000 0.00000 0.02042 0.00000BIOCARTA_INFLAM_PATHWAY
0.09654 0.02031 0.00002 0.01185BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
0.00017 0.00022 0.00000 0.00000SANA_TNF_SIGNALING_UP
0.02435 0.01012 0.01997 0.16410DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN
0.02769 0.01129 0.00621 0.00002SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.00000 0.00004 0.00313 0.00011FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.03323 0.00602 0.19140 0.00000RICKMAN_HEAD_AND_NECK_CANCER_C
0.00217 0.00162 0.01533 0.00010WANG_METHYLATED_IN_BREAST_CANCER
0.01150 0.02501 0.06063 0.00014XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.09082 0.02496 0.10062 0.17326EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.00065 0.00022 0.01031 0.00002ONDER_CDH1_TARGETS_2_DN
0.08354 0.01901 0.02102 0.00079SENESE_HDAC1_TARGETS_UP
0.16617 0.04786 0.02010 0.01565LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.00080 0.00030 0.00008 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.00075 0.00019 0.05209 0.03679SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.01612 0.00039 0.00000 0.00002KIM_WT1_TARGETS_UP
0.07491 0.00979 0.04896 0.00076SENESE_HDAC3_TARGETS_UP
0.04586 0.06209 0.12696 0.00217KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.07697 0.00405 0.00512 0.00021ONDER_CDH1_TARGETS_1_DN
0.00145 0.00200 0.01719 0.00000KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.00000 0.00000 0.00000 0.00044UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.12191 0.04783 0.00002 0.00015KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.03005 0.01449 0.12825 0.15379BIOCARTA_GRANULOCYTES_PATHWAY
0.05410 0.01447 0.08024 0.11054DORSAM_HOXA9_TARGETS_DN
0.00000 0.00006 0.11528 0.08966HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.01073 0.00177 0.10056 0.00015DASU_IL6_SIGNALING_UP
0.01114 0.00028 0.00024 0.01098ELVIDGE_HYPOXIA_BY_DMOG_UP
0.02376 0.00086 0.00229 0.00004AMIT_EGF_RESPONSE_120_MCF10A
0.00024 0.00037 0.00000 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00000 0.00000 0.00000 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.08451 0.04370 0.00076 0.00000ZUCCHI_METASTASIS_DN
0.16977 0.04236 0.13584 0.11099BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.12398 0.04754 0.10020 0.00005RUTELLA_RESPONSE_TO_HGF_UP
0.02502 0.02844 0.00000 0.00005PRAMOONJAGO_SOX4_TARGETS_UP
0.01754 0.01530 0.18682 0.02507WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.00000 0.00000 0.00000 0.02690PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.07123 0.14239 0.00291 0.08745YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1